CME / CNE Programs

Talk Introduction:

This talk reviews menopausal hormone therapy (MHT) in contemporary practice, with a practical framework for primary care physicians and nurses. It covers who should be considered for MHT—primarily individuals with moderate to severe vasomotor symptoms or genitourinary syndrome of menopause, with individualized assessment of risks/benefits based on age, time since menopause, and comorbidities. Another important aspect is to choose the right estrogen and progestogen, tailoring to symptom profile and risk. Non-hormonal options (e.g., SSRIs/SNRIs, gabapentinoids, neurokinin B target therapy) are presented as alternatives. Practical guidance on duration of therapy, criteria for continuation vs. stopping, and strategies for tapering are provided. A central emphasis is placed on lifestyle modification—regular physical activity, weight management, sleep optimization, smoking cessation, alcohol moderation, and stress reduction—as integral to symptom control and cardiovascular/bone health.

CME Point: 1 (A post-meeting evaluation is required.) (AA16786)

Successful registrants will receive a Zoom link after the deadline.